| 000 | 01783 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517043535.0 | ||
| 264 | 0 | _c20160715 | |
| 008 | 201607s 0 0 eng d | ||
| 022 | _a1432-0711 | ||
| 024 | 7 |
_a10.1007/s00404-015-3824-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNomura, Hidetaka | |
| 245 | 0 | 0 |
_aLong-term outcomes of fertility-sparing treatment of atypical polypoid adenomyoma with medroxyprogesterone acetate. _h[electronic resource] |
| 260 |
_bArchives of gynecology and obstetrics _cJan 2016 |
||
| 300 |
_a177-181 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenomyoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Endometrioid _xdrug therapy |
| 650 | 0 | 4 |
_aEndometrial Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFertility |
| 650 | 0 | 4 | _aFertility Preservation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHysterectomy |
| 650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy Rate |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aUterine Neoplasms _xdrug therapy |
| 700 | 1 | _aSugiyama, Yuko | |
| 700 | 1 | _aTanigawa, Terumi | |
| 700 | 1 | _aMatoda, Maki | |
| 700 | 1 | _aKanao, Hiroyuki | |
| 700 | 1 | _aKondo, Eiji | |
| 700 | 1 | _aTakeshima, Nobuhiro | |
| 773 | 0 |
_tArchives of gynecology and obstetrics _gvol. 293 _gno. 1 _gp. 177-181 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00404-015-3824-9 _zAvailable from publisher's website |
| 999 |
_c25108300 _d25108300 |
||